News

An update on the first person to get the Alzheimer's treatment Leqembi at MUSC Health, plus what a specialist wants people to know.

Researchers at MUSC Hollings Cancer Center are working to develop new drug combinations for people with treatment-resistant cancer.

A new modeling study provides insight for guideline-writing bodies on who should be screened for anal cancer, how often and with which method.

Ten years after Emanuel AME Church shootings stunned people across country, a look at lessons learned from tragic event and aftermath.

Two Hollings cancer researchers are the sole South Carolinians selected for a life sciences entrepreneurship accelerator.

With $26.5 million in new funding, SCTR will clear the way for the translation of research breakthroughs into clinics and communities.

A Hollings researcher is working on an idea to help oral oncologists better predict which patients are likely to develop cancer.

Doctoral candidate Amber Hazzard has been named one of 17 AAAS Mass Media Fellows for 2025.

Two Hollings Cancer Center researchers are studying new ways to bring depression treatment to cancer survivors.

Understanding who is using the latest nicotine product – oral nicotine pouches – is the key to developing future research on the pouches' effects.